UK begins trials of Ebola vaccine developed in just eight weeks
The UK has authorized clinical trials for a new Ebola vaccine developed by the University of Oxford in just eight weeks. The trial will involve 50 healthy volunteers to test the vaccine's efficacy against the current outbreak in the Democratic Republic of the Congo.
Why it matters
Rapid vaccine development is critical for containing outbreaks in conflict zones where mobile populations make disease control difficult.
Image source, BBC/Trevor Lloyd Image caption, Researcher Alex Sampson holds the experimental Ebola vaccine
The article provides factual reporting on a medical development without political or ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in